Onyx Biotec Limited (NSE:ONYX)
India · Delayed Price · Currency is INR 37.25
+0.20 (0.54%)
At close: Oct 16, 2026
Onyx Biotec Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 675 | 616 | 1,052 | - | - | - | |
Market Cap Growth | -11.31% | -41.38% | - | - | - | - |
Enterprise Value | 787 | 702 | 1,338 | - | - | - |
Last Close Price | 37.25 | 34.00 | 58.00 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 21.23 | - | - | - |
PS Ratio | 0.97 | 0.89 | 1.70 | - | - | - |
PB Ratio | 1.22 | 1.11 | 1.89 | - | - | - |
P/TBV Ratio | 1.22 | 1.11 | 1.89 | - | - | - |
P/FCF Ratio | - | - | 290.43 | - | - | - |
P/OCF Ratio | - | - | 74.22 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.13 | 1.01 | 2.16 | - | - | - |
EV/EBITDA Ratio | 23.02 | 20.54 | 12.90 | - | - | - |
EV/EBIT Ratio | 215.49 | 192.25 | 18.27 | - | - | - |
EV/FCF Ratio | - | - | 369.54 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.27 | 0.27 | 0.22 | 1.22 | 1.61 | 0.75 |
Debt / EBITDA Ratio | 4.44 | 4.44 | 1.20 | 3.68 | 6.43 | 2.14 |
Debt / FCF Ratio | - | - | 34.41 | - | - | - |
Net Debt / Equity Ratio | 0.20 | 0.20 | 0.07 | 1.16 | 1.61 | 0.75 |
Net Debt / EBITDA Ratio | 3.26 | 3.26 | 0.37 | 3.50 | 6.43 | 2.14 |
Net Debt / FCF Ratio | -1.72 | -1.72 | 10.62 | -17.18 | -1.77 | -2.31 |
Asset Turnover | 0.75 | 0.75 | 0.75 | 0.81 | 0.83 | - |
Inventory Turnover | 3.50 | 3.50 | 3.18 | 4.76 | 4.72 | - |
Quick Ratio | 0.97 | 0.97 | 1.12 | 0.75 | 0.26 | 0.84 |
Current Ratio | 1.58 | 1.58 | 1.91 | 1.31 | 0.72 | 1.44 |
Return on Equity (ROE) | -0.39% | -0.39% | 12.25% | 16.71% | 10.67% | - |
Return on Assets (ROA) | 0.24% | 0.24% | 5.54% | 6.12% | 4.00% | - |
Return on Invested Capital (ROIC) | 0.55% | 0.58% | 9.82% | 10.32% | 5.82% | 13.21% |
Return on Capital Employed (ROCE) | 0.60% | 0.60% | 11.20% | 12.60% | 7.90% | 16.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -0.32% | -0.35% | 4.71% | - | - | - |
FCF Yield | -9.60% | -10.51% | 0.34% | - | - | - |
Buyback Yield / Dilution | -21.03% | -21.03% | -25.51% | -1.13% | - | - |